Activity: Membership types › Membership of peer review panel or committee
Description
PROMISE will continue advancing scientific knowledge on Respiratory Syncytial Virus (RSV) to better inform public health strategies and to support the development and monitoring of novel immunisation and therapeutics against this potentially deadly virus in the paediatric and elderly populations. PROMISE builds on RESCEU’s results, another Innovative Medicines Initiative project focusing on RSV. PROMISE is funded by the EU (€7,024,387).